{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:14:52Z","timestamp":1793754892395,"version":"4.6.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T00:00:00Z","timestamp":1720224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T00:00:00Z","timestamp":1720224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>To evaluate the effectiveness of cryoablation compared to partial nephrectomy in patients with stage IA papillary and chromophobe renal cell carcinoma (pRCC; chRCC).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Material and methods<\/jats:title>\n                <jats:p>The 2004\u20132016 National Cancer Database was queried for adult patients with stage IA pRCC or chRCC treated with cryoablation or partial nephrectomy. Patients receiving systemic therapy or radiotherapy, as well as those with bilateral RCC or prior malignant disease were excluded. Overall survival (OS) was assessed using Kaplan\u2013Meier plots and Cox proportional hazard regression models. Nearest neighbor propensity matching (1:1 cryoablation:partial nephrectomy, stratified for pRCC and chRCC) was used to account for potential confounders.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 11122 stage IA renal cell carcinoma patients were included (pRCC 8030; chRCC 3092). Cryoablation was performed in 607 (5.5%) patients, and partial nephrectomy in 10515 (94.5%) patients. A higher likelihood of cryoablation treatment was observed in older patients with non-private healthcare insurance, as well as in those with smaller diameter low-grade pRCC treated at non-academic centers in specific US geographic regions. After propensity score matching to account for confounders, there was no statistically significant difference in OS comparing cryoablation vs partial nephrectomy in patients with pRCC (HR\u2009=\u20091.3, 95% CI: 0.96\u20131.75, <jats:italic>p<\/jats:italic>\u2009=\u20090.09) and those with chRCC (HR\u2009=\u20091.38, 95% CI: 0.67\u20132.82, <jats:italic>p<\/jats:italic>\u2009=\u20090.38).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>After accounting for confounders, cryoablation, and partial nephrectomy demonstrated comparable OS in patients with stage IA papillary and chromophobe RCC. Cryoablation is a reasonable treatment alternative to partial nephrectomy for these histological RCC subtypes when radiologically suspected or diagnosed after biopsy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Critical relevance statement<\/jats:title>\n                <jats:p>Cryoablation might be considered as an upfront treatment alternative to partial nephrectomy in patients with papillary and chromophobe stage IA renal cell carcinoma, as both treatment approaches yield comparable oncological outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Key Points<\/jats:title>\n                <jats:p><jats:list list-type=\"bullet\">\n                  <jats:list-item>\n                    <jats:p>The utilization of cryoablation for stage IA papillary and chromophobe RCC increases.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>In the National Cancer Database, we found specific patterns of use of cryoablation.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>Cryoablation and partial nephrectomy demonstrate comparable outcomes after accounting for confounders.<\/jats:p>\n                  <\/jats:list-item>\n                <\/jats:list><\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s13244-024-01749-x","type":"journal-article","created":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T19:01:53Z","timestamp":1720292513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Stage IA papillary and chromophobe renal cell carcinoma: effectiveness of cryoablation and partial nephrectomy"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7305-9271","authenticated-orcid":false,"given":"Annemarie","family":"Uhlig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Uhlig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Shuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,6]]},"reference":[{"key":"1749_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"1749_CR2","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.euo.2018.08.023","volume":"2","author":"HD Patel","year":"2019","unstructured":"Patel HD, Gupta M, Joice GA et al (2019) Clinical stage migration and survival for renal cell carcinoma in the United States. Eur Urol Oncol 2:343\u2013348","journal-title":"Eur Urol Oncol"},{"key":"1749_CR3","unstructured":"Edge SB, Edge SB (2017) AJCC cancer staging manual 8th ed. Springer"},{"key":"1749_CR4","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1200\/JCO.2005.07.055","volume":"23","author":"J-J Patard","year":"2005","unstructured":"Patard J-J, Leray E, Rioux-Leclercq N et al (2005) Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol 23:2763\u20132771","journal-title":"J Clin Oncol"},{"key":"1749_CR5","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1016\/j.ejca.2012.05.002","volume":"48","author":"S Steffens","year":"2012","unstructured":"Steffens S, Janssen M, Roos FC et al (2012) Incidence and long-term prognosis of papillary compared to clear cell renal cell carcinoma-a multicentre study. Eur J Cancer 48:2347\u20132352","journal-title":"Eur J Cancer"},{"key":"1749_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1464-410X.2011.10690.x","volume":"110","author":"A Volpe","year":"2012","unstructured":"Volpe A, Novara G, Antonelli A et al (2012) Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series. BJU Int 110:76\u201383","journal-title":"BJU Int"},{"key":"1749_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/JU.0000000000001911","volume":"206","author":"SC Campbell","year":"2021","unstructured":"Campbell SC, Clark PE, Chang SS et al (2021) Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: part I. J Urol 206:199\u2013208","journal-title":"J Urol"},{"key":"1749_CR8","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.eururo.2019.02.011","volume":"75","author":"B Ljungberg","year":"2019","unstructured":"Ljungberg B, Albiges L, Abu-Ghanem Y et al (2019) European Association of Urology Guidelines on renal cell carcinoma: the 2019 update. Eur Urol 75:799\u2013810","journal-title":"Eur Urol"},{"key":"1749_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.6004\/jnccn.2022.0001","volume":"20","author":"RJ Motzer","year":"2022","unstructured":"Motzer RJ, Jonasch E, Agarwal N et al (2022) Kidney cancer, Version 3.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw 20:71\u201390","journal-title":"J Natl Compr Cancer Netw"},{"key":"1749_CR10","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1148\/rg.304095134","volume":"30","author":"BC Allen","year":"2010","unstructured":"Allen BC, Remer EM (2010) Percutaneous cryoablation of renal tumors: patient selection, technique, and postprocedural imaging. Radiographics 30:887\u2013900","journal-title":"Radiographics"},{"key":"1749_CR11","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1148\/radiol.2018180249","volume":"289","author":"DJ Breen","year":"2018","unstructured":"Breen DJ, King AJ, Patel N et al (2018) Image-guided cryoablation for sporadic renal cell carcinoma: three- and 5-year outcomes in 220 patients with biopsy-proven renal cell carcinoma. Radiology 289:554\u2013561","journal-title":"Radiology"},{"key":"1749_CR12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.juro.2010.03.013","volume":"184","author":"A Sidana","year":"2010","unstructured":"Sidana A, Aggarwal P, Feng Z et al (2010) Complications of renal cryoablation: a single center experience. J Urol 184:42\u201347","journal-title":"J Urol"},{"key":"1749_CR13","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.eururo.2015.03.027","volume":"69","author":"H Zargar","year":"2016","unstructured":"Zargar H, Atwell TD, Cadeddu JA et al (2016) Cryoablation for small renal masses: selection criteria, complications, and functional and oncologic results. Eur Urol 69:116\u2013128","journal-title":"Eur Urol"},{"key":"1749_CR14","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1089\/end.2019.0882","volume":"34","author":"NA Pickersgill","year":"2020","unstructured":"Pickersgill NA, Vetter JM, Kim EH et al (2020) Ten-year experience with percutaneous cryoablation of renal tumors: tumor size predicts disease progression J Endourol 34:1211\u20131217","journal-title":"J Endourol"},{"key":"1749_CR15","doi-asserted-by":"crossref","unstructured":"Uhlig J, Leha A, Delonge LM et al (2020) Radiomic features and machine learning for the discrimination of renal tumor histological subtypes: a pragmatic study using clinical-routine computed tomography. Cancers 12:3010","DOI":"10.3390\/cancers12103010"},{"key":"1749_CR16","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/RLU.0000000000000875","volume":"40","author":"M Takahashi","year":"2015","unstructured":"Takahashi M, Kume H, Koyama K et al (2015) Preoperative evaluation of renal cell carcinoma by using 18F-FDG PET\/CT. Clin Nucl Med 40:936\u2013940","journal-title":"Clin Nucl Med"},{"key":"1749_CR17","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s00330-018-5660-3","volume":"29","author":"J Uhlig","year":"2019","unstructured":"Uhlig J, Strauss A, R\u00fccker G et al (2019) Partial nephrectomy versus ablative techniques for small renal masses: a systematic review and network meta-analysis. Eur Radiol 29:1293\u20131307","journal-title":"Eur Radiol"},{"key":"1749_CR18","unstructured":"American College of Surgeons (2021) National Cancer Database. Available via https:\/\/www.facs.org\/quality-programs\/cancer\/ncdb. Accessed 29 Aug 2021"},{"key":"1749_CR19","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1016\/j.jclinepi.2013.01.013","volume":"66","author":"EA Stuart","year":"2013","unstructured":"Stuart EA, Lee BK, Leacy FP (2013) Prognostic score-based balance measures can be a useful diagnostic for propensity score methods in comparative effectiveness research. J Clin Epidemiol 66:S84\u2013S90.e81","journal-title":"J Clin Epidemiol"},{"key":"1749_CR20","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.juro.2015.03.115","volume":"194","author":"AH Lay","year":"2015","unstructured":"Lay AH, Faddegon S, Olweny EO et al (2015) Oncologic efficacy of radio frequency ablation for small renal masses: clear cell vs papillary subtype. J Urol 194:653\u2013657","journal-title":"J Urol"},{"key":"1749_CR21","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.jvir.2018.02.029","volume":"29","author":"MM Haddad","year":"2018","unstructured":"Haddad MM, Schmit GD, Kurup AN et al (2018) Percutaneous cryoablation of solitary, sporadic renal cell carcinoma: outcome analysis based on clear-cell versus papillary subtypes. J Vasc Inter Radiol 29:1122\u20131126","journal-title":"J Vasc Inter Radiol"},{"key":"1749_CR22","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1464-410X.2006.06554.x","volume":"99","author":"RL O\u2019Malley","year":"2007","unstructured":"O\u2019Malley RL, Berger AD, Kanofsky JA et al (2007) A matched-cohort comparison of laparoscopic cryoablation and laparoscopic partial nephrectomy for treating renal masses. BJU Int 99:395\u2013398","journal-title":"BJU Int"},{"key":"1749_CR23","doi-asserted-by":"publisher","first-page":"184","DOI":"10.4143\/crt.2008.40.4.184","volume":"40","author":"YH Ko","year":"2008","unstructured":"Ko YH, Park HS, Moon du G et al (2008) A matched-cohort comparison of laparoscopic renal cryoablation using ultra-thin cryoprobes with open partial nephrectomy for the treatment of small renal cell carcinoma. Cancer Res Treat 40:184\u2013189","journal-title":"Cancer Res Treat"},{"key":"1749_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.urology.2005.06.114","volume":"66","author":"MM Desai","year":"2005","unstructured":"Desai MM, Aron M, Gill IS (2005) Laparoscopic partial nephrectomy versus laparoscopic cryoablation for the small renal tumor. Urology 66:23\u201328","journal-title":"Urology"},{"key":"1749_CR25","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1464-410X.2011.10287.x","volume":"109","author":"GP Haber","year":"2012","unstructured":"Haber GP, Lee MC, Crouzet S et al (2012) Tumour in solitary kidney: laparoscopic partial nephrectomy vs laparoscopic cryoablation. BJU Int 109:118\u2013124","journal-title":"BJU Int"},{"key":"1749_CR26","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.eururo.2012.01.007","volume":"61","author":"J Guillotreau","year":"2012","unstructured":"Guillotreau J, Haber GP, Autorino R et al (2012) Robotic partial nephrectomy versus laparoscopic cryoablation for the small renal mass. Eur Urol 61:899\u2013904","journal-title":"Eur Urol"},{"key":"1749_CR27","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1089\/end.2010.0615","volume":"25","author":"T Klatte","year":"2011","unstructured":"Klatte T, Mauermann J, Heinz-Peer G et al (2011) Perioperative, oncologic, and functional outcomes of laparoscopic renal cryoablation and open partial nephrectomy: a matched pair analysis. J Endourol 25:991\u2013997","journal-title":"J Endourol"},{"key":"1749_CR28","doi-asserted-by":"publisher","first-page":"259.e251","DOI":"10.1016\/j.urolonc.2016.01.005","volume":"34","author":"DP Nguyen","year":"2016","unstructured":"Nguyen DP, Vertosick EA, Corradi RB et al (2016) Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy. Urol Oncol 34:259.e251\u2013258","journal-title":"Urol Oncol"},{"key":"1749_CR29","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1016\/j.juro.2009.07.019","volume":"182","author":"PE Teloken","year":"2009","unstructured":"Teloken PE, Thompson RH, Tickoo SK et al (2009) Prognostic impact of histological subtype on surgically treated localized renal cell carcinoma. J Urol 182:2132\u20132136","journal-title":"J Urol"},{"key":"1749_CR30","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.juro.2009.12.035","volume":"183","author":"BC Leibovich","year":"2010","unstructured":"Leibovich BC, Lohse CM, Crispen PL et al (2010) Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. J Urol 183:1309\u20131316","journal-title":"J Urol"},{"key":"1749_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02245-1","volume":"8","author":"J Espana-Agusti","year":"2017","unstructured":"Espana-Agusti J, Warren A, Chew SK et al (2017) Loss of PBRM1 rescues VHL dependent replication stress to promote renal carcinogenesis. Nat Commun 8:2026","journal-title":"Nat Commun"},{"key":"1749_CR32","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20170951","volume":"92","author":"SY Park","year":"2018","unstructured":"Park SY, Won JY, Oh YT et al (2018) Assessment of cold sink effect in postulated renal cryoablation by analyzing radiographic ice ball on computed tomography. Br J Radiol 92:20170951","journal-title":"Br J Radiol"},{"key":"1749_CR33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1053\/j.tvir.2007.08.005","volume":"10","author":"JL Hinshaw","year":"2007","unstructured":"Hinshaw JL, Lee Jr FT (2007) Cryoablation for liver cancer. Tech Vasc Interv Radiol 10:47\u201357","journal-title":"Tech Vasc Interv Radiol"},{"key":"1749_CR34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1158\/1078-0432.CCR-17-1555","volume":"24","author":"LB Jilaveanu","year":"2018","unstructured":"Jilaveanu LB, Puligandla M, Weiss SA et al (2018) Tumor microvessel density as a prognostic marker in high-risk renal cell carcinoma patients treated on ECOG-ACRIN E2805. Clin Cancer Res 24:217\u2013223","journal-title":"Clin Cancer Res"},{"key":"1749_CR35","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1148\/radiol.2018172960","volume":"288","author":"J Uhlig","year":"2018","unstructured":"Uhlig J, Kokabi N, Xing M, Kim HS (2018) Ablation versus resection for stage 1A renal cell carcinoma: national variation in clinical management and selected outcomes. Radiology 288:889\u2013897","journal-title":"Radiology"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-024-01749-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-024-01749-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-024-01749-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T19:02:26Z","timestamp":1720292546000},"score":1,"resource":{"primary":{"URL":"https:\/\/insightsimaging.springeropen.com\/articles\/10.1186\/s13244-024-01749-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,6]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1749"],"URL":"https:\/\/doi.org\/10.1186\/s13244-024-01749-x","relation":{},"ISSN":["1869-4101"],"issn-type":[{"value":"1869-4101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,6]]},"assertion":[{"value":"29 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is HIPAA compliant and was approved by the institutional review board at Yale University. All data originates from the NCDB which contains only completely de-identified patient data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"171"}}